These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 22538993)

  • 21. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.
    Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L
    Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic control indicators in patients with neonatal diabetes mellitus.
    Suzuki S; Koga M
    World J Diabetes; 2014 Apr; 5(2):198-208. PubMed ID: 24748932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent topics in chemical and clinical research on glycated albumin.
    Ueda Y; Matsumoto H
    J Diabetes Sci Technol; 2015 Mar; 9(2):177-82. PubMed ID: 25614014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycated serum albumin: a potential disease marker and an intermediate index of diabetes control.
    Raghav A; Ahmad J
    Diabetes Metab Syndr; 2014; 8(4):245-51. PubMed ID: 25311816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abundance matters: role of albumin in diabetes, a proteomics perspective.
    Bhat S; Jagadeeshaprasad MG; Venkatasubramani V; Kulkarni MJ
    Expert Rev Proteomics; 2017 Aug; 14(8):677-689. PubMed ID: 28689445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation.
    Roohk HV; Zaidi AR; Patel D
    Inflamm Res; 2018 Jan; 67(1):21-30. PubMed ID: 29022053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycated albumin in patients with neonatal diabetes mellitus is apparently low in relation to glycemia compared with that in patients with type 1 diabetes mellitus.
    Suzuki S; Koga M; Takahashi H; Matsuo K; Tanahashi Y; Azuma H
    Horm Res Paediatr; 2012; 77(5):273-6. PubMed ID: 22538993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycated albumin and diabetes mellitus.
    Furusyo N; Hayashi J
    Biochim Biophys Acta; 2013 Dec; 1830(12):5509-14. PubMed ID: 23673238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of glycated albumin as another glycemic control marker.
    Koga M; Kasayama S
    Endocr J; 2010; 57(9):751-62. PubMed ID: 20724796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glycated albumin as a marker of glycemia in diabetes and its vascular complications].
    Warwas M; Żurawska-Płaksej E; Ciężka D; Piwowar A
    Postepy Hig Med Dosw (Online); 2015 May; 69():638-48. PubMed ID: 25983302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
    Gan T; Liao B; Xu G
    J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.